Patents by Inventor Yunsen LI

Yunsen LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11767286
    Abstract: Provided in the present invention are a phenylpropionate compound, a preparation method for same, and applications. The phenylpropionate compound has the structure as represented by formula I. The phenylpropionate compound of the present invention, a pharmaceutically acceptable salt, a solvate, a prodrug, and a tautomer or stereochemical isomer or pharmaceutical composition of the compound provide improved anti-inflammatory and antiplatelet effects and, at the same time, provide an extended time window for treatment, are free of obvious side effects, safe and effective, applicable in an antithrombus, anti-inflammatory, and cerebral stroke treating medicament, and have broad application prospects.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: September 26, 2023
    Assignee: SUZHOU PHARMAVAN CO., LTD
    Inventors: Qian Liu, Yunsen Li, Shiping Deng, Yuan Gao, Shanning Lou, Yunhui Yu, Chuanliang Jiang
  • Publication number: 20200331842
    Abstract: Provided in the present invention are a phenylpropionate compound, a preparation method for same, and applications. The phenylpropionate compound has the structure as represented by formula I. The phenylpropionate compound of the present invention, a pharmaceutically acceptable salt, a solvate, a prodrug, and a tautomer or stereochemical isomer or pharmaceutical composition of the compound provide improved anti-inflammatory and antiplatelet effects and, at the same time, provide an extended time window for treatment, are free of obvious side effects, safe and effective, applicable in an antithrombus, anti-inflammatory, and cerebral stroke treating medicament, and have broad application prospects.
    Type: Application
    Filed: January 19, 2018
    Publication date: October 22, 2020
    Applicant: SUZHOU PHARMAVAN CO., LTD
    Inventors: Qian LIU, Yunsen LI, Shiping DENG, Yuan GAO, Shanning LOU, Yunhui YU, Chuanliang JIANG
  • Publication number: 20200261375
    Abstract: Disclosed is the use of (+)-2-borneol in the preparation of a drug for promoting the upregulation of the expression of sphingosine kinase-1 and/or BDNF (a brain-derived neurotrophic factor). Herein, (+)-2-borneol can be used to prepare a drug for promoting the upregulation of the expression of the sphingosine kinase-1 and/or the brain-derived neurotrophic factor. The drug can induce astrocyte spreading and migration, oligodendrocyte differentiation and survival, and neurite growth and nerve regeneration, and can promote the upregulation of the expression of the brain-derived neurotrophic factor, promote the survival of neurons and the growth of axons, inhibit the expansion of the infarct volume, and achieve the effect of repairing damage at the site of an immediate injury while preventing further expansion of the infarct area to completely treat brain damage, so that the long-term therapeutic effect thereof is significantly improved.
    Type: Application
    Filed: June 7, 2017
    Publication date: August 20, 2020
    Inventors: Yunsen LI, Shiping DENG, Yong LI, Chuanliang JIANG, Yunhui YU